PBLS Parabilis Medicines, Inc.
Parabilis Medicines, Inc. (PBLS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: July 22, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Buy | 47,250 | $29.77 | $1.4M | 26,529,686 | |||
| 3 fills | Buy | 65,923 | $29.25 | $1.9M | 26,482,436 | ||
| 2 fills | Buy | 131,420 | $27.28 | $3.6M | 26,416,513 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.